MET Stats & Data
CCN(C)CCC1=CNC2=CC=CC=C21MYEGVMLMDWYPOA-UHFFFAOYSA-NReceptor Profile
Receptor Actions
History & Culture
MET was first documented in scientific literature in 1981, appearing in Michael Valentine Smith's book "Psychedelic Chemistry." The compound subsequently received a brief entry in Alexander Shulgin's 1997 publication "TiHKAL" (Tryptamines I Have Known and Loved), though it did not receive extensive characterization in that work. The substance emerged on the European drug market as a novel designer drug in 2014, marking its first appearance in recreational contexts. By mid-2016, MET had become available through online research chemical vendors, where it continues to be distributed for recreational and entheogenic purposes.
Toxicity
PsychonautWikiThe toxicity and long-term health effects of recreational MET use do not seem to have been studied in any scientific context and the exact toxic dose is unknown. This is because MET is a research chemical with very little history of human usage. Anecdotal evidence from people within the community who have tried MET suggest that there are no negative health effects attributed to simply trying the substance by itself at low to moderate doses and using it very sparingly (but nothing can be completely guaranteed). Independent research should always be done to ensure that a combination of two or more substances is safe before consumption. It is strongly recommended that one use harm reduction practices when using this substance.
Effect Profile
Curated + 9 ReportsStrong visuals with mild headspace and body load
Duration Timeline
BluelightTolerance & Pharmacokinetics
drugs.wikiTolerance Decay
Cross-Tolerances
Experience Report Analysis
ErowidDemographics
Gender Distribution
Too few reports for a chart: gender is known from 14 reports, and a split is drawn only from 20 reports or more. Counts are shown instead. Why 20?
- Male 11 of 14
- Female 2 of 14
- Not Specified 1 of 14
Age Distribution
Reports Over Time
Effect Analysis
ErowidEffects aggregated from 9 experience reports (9 single-substance Erowid)
Effect Sentiment Distribution
Confidence Distribution
Each bar is the share of reports mentioning the effect; its whisker, and the band on the rows below, is the 95% interval: where the share could plausibly be with other reports of the same kind.
Too few reports for bars: these effects come from 9 single-substance Erowid reports, and a bar is drawn only from 20 reports or more. With fewer, a percentage cannot tell a common effect from a rare one. Counts are shown instead. Why 20?
Positive Effects 6
Adverse Effects 0
Real-World Dose Distribution
ErowidFrom 15 of 21 recorded dose entries: those that state a weight (mg, g or µg), in routes with at least five of them. Values above Q3 + 3×IQR, far above what people typically take, are left out; they can include real heavy doses and overdoses, not only mistakes.
Smoked (n=15)
Form / Preparation
Most common forms and preparations, as a share of the 11 reports that give one
Too few reports for bars: these forms come from 11 reports, and a bar is drawn only from 20 reports or more. With fewer, a percentage cannot tell a common effect from a rare one. Counts are shown instead. Why 20?
- Powder / Crystals 10 of 11
Redose Patterns
Redosing behavior across 11 reports
Too few reports for a chart: redosing is known from 11 reports, and a split is drawn only from 20 reports or more. Counts are shown instead. Why 20?
- Single dose 8 of 11
- Redosed 3 of 11
Legal Status
| Country | Status | Notes |
|---|---|---|
| Germany | NpSG (Controlled) | Controlled under the Neue-psychoaktive-Stoffe-Gesetz (New Psychoactive Substances Act) as of July 18, 2019. Production, import with intent to distribute, administration to others, and trading are punishable offenses. Possession is prohibited but not subject to criminal penalty. |
| Japan | Controlled | Designated as a controlled substance as of March 20, 2023. |
| New Zealand | Class C | Controlled as a structural analogue of DMT under New Zealand's drug legislation. |
| Switzerland | Uncontrolled | Not listed under Buchstabe A, B, C, or D of Swiss controlled substances legislation. May be considered legal for possession. |
| United Kingdom | Class A | Controlled under the Misuse of Drugs Act 1971 via a generic clause added in 1977 that covers tryptamine derivatives modified by alkyl substitution at the nitrogen atom of the side chain. |
| United States | Unscheduled (Analogue Act may apply) | MET is not specifically scheduled under the Controlled Substances Act. However, it may be considered a controlled substance analogue of DMT or DET, meaning sales for human consumption or possession with intent to ingest could potentially be prosecuted under the Federal Analogue Act. |